HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation (Q39501616)

12 September 2017

HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation (English)

1 reference

12 September 2017

1 reference

6

1 reference

12 September 2017

Olli-Pekka Kallioniemi

11

1 reference

12 September 2017

10

M Perälä

1 reference

12 September 2017

S Haapa-Paananen

1

1 reference

12 September 2017

S Kiviluoto

2

1 reference

12 September 2017

M Waltari

3

1 reference

12 September 2017

M Puputti

4

1 reference

12 September 2017

J P Mpindi

5

1 reference

12 September 2017

O Tynninen

7

1 reference

12 September 2017

H Haapasalo

8

1 reference

12 September 2017

H Joensuu

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

25 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

31

1 reference

12 September 2017

10

1 reference

12 September 2017

1299-1310

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.316

12 September 2017

0 references

cites work

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Induction of neuronal apoptosis by expression of Hes6 via p53-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Hes6 promotes cortical neurogenesis and inhibits Hes1 transcription repression activity by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Target specificities of Drosophila enhancer of split basic helix-loop-helix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Hes6 inhibits astrocyte differentiation and promotes neurogenesis through different mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Applications of emerging molecular technologies in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Rembrandt: helping personalized medicine become a reality through integrative translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Pro-neural transcription factors as cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Content and activity of cAMP response element-binding protein regulate platelet-derived growth factor receptor-alpha content in vascular smooth muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Integrated network analysis platform for protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

Hes6 controls cell proliferation via interaction with cAMP-response element-binding protein-binding protein in the promyelocytic leukemia nuclear body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

UltraRapid communication : nuclear factor-kappaB and cAMP response element binding protein mediate opposite transcriptional effects on the flk-1/KDR gene promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.316

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.316

1 reference

12 September 2017

1 reference